Department of Surgery, Daejeon St. Mary's Hospital, The Catholic University of Korea, Daejeon, Republic of Korea.
Int J Surg. 2013;11(9):858-63. doi: 10.1016/j.ijsu.2013.08.003. Epub 2013 Aug 17.
Total mesorectal excisions (TME) with transanal resection and coloanal anastomosis (CAA) represent one of the standard surgical treatments for low rectal cancers. We report our initial experiences with trans-abdominal trans-anal resections (TATAR) with TME, performed using a single-port laparoscopic surgeries (SPLS) approach for low rectal cancers.
Between June 2009 and April 2011, 22 low rectal cancer patients underwent SPLS TATAR with TME. SPLS was performed transumbilically or through predetermined stoma sites. Conventional laparoscopic instruments were used, and the intracorporeal procedures and range of operation did not differ. After a full laparoscopic TME to the pelvic floor muscles, the specimen was pulled through the anus. CAA was completed with transanal hand sewn sutures. Patient and tumor characteristics and operative, pathologic, and postoperative outcomes were studied.
SPLS TATAR with TME was successful in all patients. No additional incisions for trocars or conversions to open surgery were performed. The median incision length, operative time, and postoperative length of stay were 2.0 cm (range: 1.5-2.5), 260 min (range: 190-380), and 6 days (range: 4-16), respectively. The median number of harvested lymph nodes was 22 (range: 9-42). The median distal margin from the tumor was 2.0 cm (range: 0.3-4.0). No intraoperative complications were noted.
SPLS TATAR with TME was safe and feasible. In addition to cosmetic advantages, oncologic requirements for specimens, including adequate margins and sufficient lymph node harvesting could be fulfilled entirely. However, the technique and oncologic safety warrant further evaluation and prospective randomized studies.
全直肠系膜切除术(TME)联合经肛门直肠切除术和结肠肛管吻合术(CAA)是低位直肠癌的标准治疗方法之一。我们报告了使用单孔腹腔镜手术(SPLS)进行低位直肠肿瘤的经腹经肛门直肠切除术(TATAR)联合 TME 的初步经验。
2009 年 6 月至 2011 年 4 月,22 例低位直肠癌患者接受了 SPLS TATAR 联合 TME。SPLS 通过脐部或预定的造口部位进行。使用常规腹腔镜器械,并且腔内操作和手术范围没有差异。在全腹腔镜 TME 到达盆底肌肉后,将标本经肛门拉出。通过经肛门手工缝合完成 CAA。研究了患者和肿瘤特征以及手术、病理和术后结果。
所有患者均成功完成了 SPLS TATAR 联合 TME。没有进行额外的切口以放置 Trocar 或转为开放性手术。中位切口长度、手术时间和术后住院时间分别为 2.0cm(范围:1.5-2.5cm)、260 分钟(范围:190-380 分钟)和 6 天(范围:4-16 天)。中位淋巴结清扫数目为 22 枚(范围:9-42 枚)。肿瘤远端切缘中位数为 2.0cm(范围:0.3-4.0cm)。术中无并发症发生。
SPLS TATAR 联合 TME 是安全可行的。除了美容优势外,标本的肿瘤学要求,包括足够的切缘和足够的淋巴结清扫,也可以完全满足。然而,该技术和肿瘤学安全性需要进一步评估和前瞻性随机研究。